Secret ties to industry and conflicting interests in cancer research†
Version of Record online: 3 NOV 2006
Copyright © 2006 Wiley-Liss, Inc.
American Journal of Industrial Medicine
Special Issue: Ethical Considerations and Future Challenges In Occupational and Environmental Health
Volume 50, Issue 3, pages 227–233, March 2007
How to Cite
Hardell, L., Walker, M. J., Walhjalt, B., Friedman, L. S. and Richter, E. D. (2007), Secret ties to industry and conflicting interests in cancer research. Am. J. Ind. Med., 50: 227–233. doi: 10.1002/ajim.20357
An erratum to this article has been published in American Journal of Industrial Medicine.
- Issue online: 21 FEB 2007
- Version of Record online: 3 NOV 2006
- Manuscript Accepted: 17 MAY 2006
- cancer research;
- conflicts of interest;
- consulting ethics;
- industry sponsors
Recently it was reported that a Swedish professor in environmental health has for decades worked as a consultant for Philip Morris without reporting his employment to his academic employer or declaring conflicts of interest in his research. The potential for distorting the epidemiological assessments of hazard and risk through paid consultants, pretending to be independent, is not exclusive to the tobacco industry.
Documentation is drawn from peer reviewed publications, websites, documents from the Environmental Protection Agency, University reports, Wellcome Library Special Collections and the Washington Post.
Some consulting firms employ university researchers for industry work thereby disguising industry links in the income of large departments. If the industry affiliation is concealed by the scientist, biases from conflicting interests in risk assessments cannot be evaluated and dealt with properly. Furthermore, there is reason to suspect that editors and journal staff may suppress publication of scientific results that are adverse to industry owing to internal conflict of interest between editorial integrity and business needs.
Examples of these problems from Sweden, UK, and USA are presented. The shortfalls cited in this article illustrate the need for improved transparency, regulations that will help curb abuses as well as instruments for control and enforcement against abuses. Am. J. Ind. Med. 50: 227–233, 2007. © 2006 Wiley-Liss, Inc.